Viewing Study NCT01862367


Ignite Creation Date: 2025-12-25 @ 12:38 AM
Ignite Modification Date: 2026-02-01 @ 2:25 PM
Study NCT ID: NCT01862367
Status: COMPLETED
Last Update Posted: 2019-07-09
First Post: 2013-05-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Use of rFXIII in Treatment of Congenital FXIII Deficiency, a Prospective Multi-centre Observational Study
Sponsor: Novo Nordisk A/S
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Congenital Bleeding Disorder View
None Congenital FXIII Deficiency View
Keywords: